Education
About Us
Working with TipRanks
Follow Us
Gaurav Shah Insider Profile
18 Followers
Gaurav Shah, CEO, Director at Rocket Pharmaceuticals, holds 1.19M shares in Rocket Pharmaceuticals (Ticker: RCKT), holds ― shares in Tourmaline Bio (Ticker: TRML).
Gaurav Shah Rocket Pharmaceuticals (RCKT)CEO, Director
Rocket Pharmaceuticals (RCKT)
CEO, Director
Ranked #6,832 out of 103,225 Corporate Insiders
Profitable Transactions
8 out of 11 Profitable Transactions
Average Return
+24.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Gaurav Shah holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Aug 20, 2024 - Aug 20, 2025
Return:+69.40%
The most profitable trade made by Gaurav Shah
Gaurav Shah's Trading History
Rocket Pharmaceuticals
Aug 20, 2025
CEO, Director
Uninformative Sell
6.81K
$4.33M
Tourmaline Bio
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Gaurav Shah's performance on stock
You May Also Like
Gaurav Shah insider profile FAQ
What is the percentage of profitable transactions made by Gaurav Shah?
The percentage of profitable transactions made by Gaurav Shah is 73%.
What is the average return per transaction made by Gaurav Shah?
The average return per transaction made by Gaurav Shah is 24.40%.
What stocks does Gaurav Shah hold?
Gaurav Shah holds: RCKT, TRML stocks.
What was Gaurav Shah’s latest transaction?
Gaurav Shah latest transaction was an Uninformative Sell of $6.81K.
What was Gaurav Shah's most profitable transaction?
Gaurav Shah’s most profitable transaction was an Informative Sell of RCKT stock on August 20, 2024. The return on the trade was 69.40%.
What is Gaurav Shah's role in Rocket Pharmaceuticals?
Gaurav Shah's role in Rocket Pharmaceuticals is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.